The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH
The part of GLP-1s nobody tells you: medication quiets appetite, habits make it last
If that lawsuit were to succeed, or if Novo Nordisks capacity to produce were to falter, the drugs may end up back on the shortage list
The EMA, after analyzing approximately 150 reports, found no clear evidence of linking GLP-1 receptor agonists to increased risks of suicidal thought, or self-injurious behavior
See my options Can you combine retatrutide and ibuprofen NSAIDs interaction
For instance, significant gastrointestinal side effects leading to dehydration, or episodes of hypoglycaemia in susceptible individuals, might produce dizziness or light-headedness that patients interpret as vertigo